Market Overview:
The global fibrinogen concentrate market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of surgical procedures, rising prevalence of congenital fibrinogen deficiency, and growing demand for plasma-derived products. However, the high cost of treatment and lack of awareness about fibrinogen concentrate are some factors that are restraining the growth of this market. On the basis of type, human fibrinogen concentrate held a major share in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to its advantages over other types such as low risk for transmission of infections and compatibility with various blood products.
Product Definition:
A fibrinogen concentrate is a blood product that is used to help control bleeding. It is made from human plasma, and it contains high levels of the protein fibrinogen. Fibrinogen concentrate can be given by injection or infusion.
Human Fibrinogen Concentrate:
Human fibrinogen is a protein that helps in the formation of blood clots. It is also known as fibrinogen because it facilitates the process through which thrombus (clot) dissolves. Fibrinogen is manufactured naturally by the body and can be found in two forms, i.e., free form and bound form.
Others:
Others are the other ingredients in the Fibrinogen Concentrate product which includes dextrose, sodium chloride, and hydrochloric acid. The Others segment is expected to grow at a CAGR of XX% over the forecast period owing to its increasing usage in fibrinogen concentrate products for their storage as well as for their use post-thawing process.
Application Insights:
Fibrinogen is used in surgical procedures as it helps in reducing the risk of bleeding. It is used for various surgical procedures, such as cardiovascular surgeries, gastrointestinal (GI) surgeries, and others. In addition, it also has a wide range of applications in cosmetic surgery and reconstructive procedures due to its ability to form fibrin networks that are highly durable.
The use of fibrinogen concentrate during cosmetic & plastic surgery helps enhance aesthetic appeal by decreasing postoperative bruising and swelling at the site. Moreover, it also reduces long-term complications associated with these surgeries including keloid scarring and adhesion formation around organs & tissues at the site which aids in decreasing postoperative pain & discomfort over a longer period of time compared to conventional solutions.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing prevalence of thrombosis and cardiovascular diseases, growing geriatric population, rising awareness about associated risks, presence of well-established healthcare facilities and availability of advanced treatment options for fibrinogen deficiency disorders in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to improving healthcare infrastructure; increase in disposable income; rise in consumer awareness regarding early diagnosis & management of congenital disorders coupled with rapidly developing medical tourism industry which will lead to an increase demand for fibrinogen concentrate products over the next eight years.
In addition, favorable government initiatives such as “Hospital Efficient Management Program†(HEM) by Ministry of Health Labor.
Growth Factors:
- Increasing incidence of bleeding disorders and thrombotic conditions
- Growing demand for fibrinogen concentrate in surgery and trauma care
- Rising awareness about the benefits of fibrinogen concentrate therapy
- Technological advancements in fibrinogen concentrate manufacturing process
- increasing number of clinical studies supporting the use of Fibrinogen Concentrate
Scope Of The Report
Report Attributes
Report Details
Report Title
Fibrinogen Concentrate Market Research Report
By Type
Human Fibrinogen Concentrate, Others
By Application
Surgical Procedures, Congenital Fibrinogen Deficiency, Others
By Companies
CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, Greencross, Shanghai XinXing Medical, Octapharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
188
Number of Tables & Figures
132
Customization Available
Yes, the report can be customized as per your need.
Global Fibrinogen Concentrate Market Report Segments:
The global Fibrinogen Concentrate market is segmented on the basis of:
Types
Human Fibrinogen Concentrate, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Surgical Procedures, Congenital Fibrinogen Deficiency, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- CSL Behring
- LFB
- Shanghai RAAS
- Boya
- Hualan Biological Engineering
- Harbin Pacific Biopharmaceutical
- Greencross
- Shanghai XinXing Medical
- Octapharma
Highlights of The Fibrinogen Concentrate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Human Fibrinogen Concentrate
- Others
- By Application:
- Surgical Procedures
- Congenital Fibrinogen Deficiency
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fibrinogen Concentrate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Fibrinogen concentrate is a purified form of the protein fibrinogen. It is used as a blood clotting agent and to help prevent bleeding in patients undergoing surgery or other medical procedures.
Some of the major players in the fibrinogen concentrate market are CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, Greencross, Shanghai XinXing Medical, Octapharma.
The fibrinogen concentrate market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Fibrinogen Concentrate Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Fibrinogen Concentrate Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Fibrinogen Concentrate Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Fibrinogen Concentrate Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Fibrinogen Concentrate Market Size & Forecast, 2020-2028
4.5.1 Fibrinogen Concentrate Market Size and Y-o-Y Growth
4.5.2 Fibrinogen Concentrate Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Human Fibrinogen Concentrate
5.2.2 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Surgical Procedures
6.2.2 Congenital Fibrinogen Deficiency
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Fibrinogen Concentrate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Fibrinogen Concentrate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Human Fibrinogen Concentrate
9.6.2 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Surgical Procedures
9.10.2 Congenital Fibrinogen Deficiency
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Human Fibrinogen Concentrate
10.6.2 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Surgical Procedures
10.10.2 Congenital Fibrinogen Deficiency
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Human Fibrinogen Concentrate
11.6.2 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Surgical Procedures
11.10.2 Congenital Fibrinogen Deficiency
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Human Fibrinogen Concentrate
12.6.2 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Surgical Procedures
12.10.2 Congenital Fibrinogen Deficiency
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Human Fibrinogen Concentrate
13.6.2 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Surgical Procedures
13.10.2 Congenital Fibrinogen Deficiency
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Fibrinogen Concentrate Market: Competitive Dashboard
14.2 Global Fibrinogen Concentrate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 CSL Behring
14.3.2 LFB
14.3.3 Shanghai RAAS
14.3.4 Boya
14.3.5 Hualan Biological Engineering
14.3.6 Harbin Pacific Biopharmaceutical
14.3.7 Greencross
14.3.8 Shanghai XinXing Medical
14.3.9 Octapharma
